These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
102 related items for PubMed ID: 801000
21. Therapeutic effect of minor antituberculosis drugs on advanced pulmonary tuberculosis. Ando M. Nagoya J Med Sci; 1967 Jan; 29(3):261-70. PubMed ID: 6074943 [No Abstract] [Full Text] [Related]
22. [The use of kanendomycin in aerosol administration in chronic obstructive bronchopneumopathy]. Bottino G, Giannotti A, Costa E. Clin Ter; 1981 Oct 31; 99(2):165-71. PubMed ID: 7318370 [No Abstract] [Full Text] [Related]
23. [Cases of pulmonary tuberculosis in which kanamycin-resistant tubercle bacilli did not appear even after a long-term administration of kanamycin. Some consideration on the interpretation of drug resistance tests]. Tsukamura M. Kekkaku; 1971 Oct 31; 46(10):405-8. PubMed ID: 4112456 [No Abstract] [Full Text] [Related]
24. [Comparative study of two regimens, KM-TH-CS and KM-TH-EB, in retreatment cases of pulmonary tuberculosis]. Aoyagi T, Fukuhara Y, Hondo G, Matsumiya T, Murata A. Kekkaku; 1970 Jan 31; 45(1):27-36. PubMed ID: 5416951 [No Abstract] [Full Text] [Related]
25. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 2. Results of rifampicin treatment for advanced pulmonary tuberculosis patients resistant to conventional antituberculous drugs]. Kekkaku; 1971 Nov 31; 46(11):423-8. PubMed ID: 4335256 [No Abstract] [Full Text] [Related]
26. [Comparison of combination therapy of Capreomycin, ethionamide and cycloserin with that of kanamycin, ethionamide and cycloserin for the retreatment of pulmonary tuberculosis]. Kitamoto O, Oka S, Kawamori Y, Gomi J, Sugiyama K. Saishin Igaku; 1970 Jul 10; 25(7):1546-55. PubMed ID: 5451178 [No Abstract] [Full Text] [Related]
28. [A comparison of the effects of the combined therapy with CPM+1321 TH+CS, KM+1321 TH+CS and KM+1314 TH+CS in the treatment of pulmonary tuberculosis]. Iizuka Y, Iwasaki T, Fujioka K. Kekkaku; 1969 Mar 10; 44(3):109-15. PubMed ID: 5783307 [No Abstract] [Full Text] [Related]
31. [Use of prothionamide in the treatment of patients with pulmonary tuberculosis]. Voĭtova DI, Zaĭtseva TI, Leont'eva GP, Milinder NM, Charikova LP. Probl Tuberk; 1971 Mar 10; 49(7):24-7. PubMed ID: 5146091 [No Abstract] [Full Text] [Related]
32. [Early results of ethambutol treatment of chronic far advanced pulmonary tuberculosis]. Justyńska-Lukoska R, Jórdeczka S, Basa S. Gruzlica; 1971 Dec 10; 39(12):1199-203. PubMed ID: 5139238 [No Abstract] [Full Text] [Related]
33. [Clinical experimentation with a new hypoglycemic agent (glipizide)]. Forattini C. Minerva Med; 1972 Oct 06; 63(70):3816-21. PubMed ID: 4562437 [No Abstract] [Full Text] [Related]
34. [Personal experience with kanendomycin in the treatment of various infectious bronchopulmonary diseases]. Visentin G, Sapori L. Clin Ter; 1983 Apr 15; 105(1):23-7. PubMed ID: 6851451 [No Abstract] [Full Text] [Related]
35. The need for new antituberculous drugs. Dahlström G. Scand J Respir Dis Suppl; 1969 Apr 15; 69():11-3. PubMed ID: 4906370 [No Abstract] [Full Text] [Related]
36. Rifampicin in the treatment of resistant pulmonary tuberculosis. Wäre M, Lorenzen J. Scand J Respir Dis Suppl; 1970 Apr 15; 72():113-9. PubMed ID: 4990617 [No Abstract] [Full Text] [Related]